Compare ICCC & CSPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ICCC | CSPI |
|---|---|---|
| Founded | 1982 | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 93.1M | 85.6M |
| IPO Year | 1995 | 1994 |
| Metric | ICCC | CSPI |
|---|---|---|
| Price | $10.41 | $8.25 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 25.4K | ★ 73.5K |
| Earning Date | 05-15-2026 | 05-08-2026 |
| Dividend Yield | N/A | ★ 1.15% |
| EPS Growth | 53.85 | ★ 75.00 |
| EPS | ★ 0.21 | 0.04 |
| Revenue | $26,493,169.00 | ★ $58,730,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ $47.90 | $205.75 |
| Revenue Growth | ★ 51.64 | 6.36 |
| 52 Week Low | $4.52 | $7.51 |
| 52 Week High | $11.16 | $15.00 |
| Indicator | ICCC | CSPI |
|---|---|---|
| Relative Strength Index (RSI) | 57.62 | 41.95 |
| Support Level | $9.27 | $7.98 |
| Resistance Level | $10.75 | $9.09 |
| Average True Range (ATR) | 0.47 | 0.58 |
| MACD | 0.02 | -0.03 |
| Stochastic Oscillator | 55.24 | 33.33 |
ImmuCell Corp is an animal health biologics company focused on the development, manufacture, and commercialization of products intended to improve the survivability, health, and long-term performance of neonatal dairy and beef calves. Its product, First Defense, utilizes hyperimmunized bovine colostrum to provide pathogen-specific antibodies and other bioactive components. First Defense is designed to provide Immediate Immunity through orally delivered antibodies against the principal viral and bacterial causes of neonatal calf diarrhea (scours), including Escherichia coli (E.coli), bovine coronavirus, and bovine rotavirus. It has two operating segments: Scours and Mastitis. It derives the majority of the revenue from the Scours segment that consists of the First Defense product line.
CSP Inc develops and markets IT integration solutions, security products, managed IT services, cloud services, purpose-built network adapters, and high-performance cluster computer systems. The firm operates in two segments, namely Technology Solutions, where the company focuses on value-added reseller integrated solutions, including third-party hardware, software, and technical computer-related consulting, and High-Performance Products segments, where the company designs, manufactures, and delivers products and services to customers that require specialized cybersecurity services, networking, and signal processing. It generates a majority of its revenue from the Technology Solutions segment. Geographically, the company generates the majority of its revenue from the Americas.